United States

Analyst Research Report Snapshot


Valeant Pharmaceuticals International, Inc.






27 May 2015





Companies referenced:

Available for Immediate Download

Valeant Pharmaceuticals International, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Valeant Pharmaceuticals International, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Valeant Pharmaceuticals International, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Valeant Pharmaceuticals International, Inc. including a breakdown and examination of key business segments - Intelligence on Valeant Pharmaceuticals International, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Valeant Pharmaceuticals International, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Valeant Pharmaceuticals International (Valeant) operates as a multinational specialty pharmaceutical company. It develops, manufactures and markets pharmaceutical products and medical devices. The company operates in Americas, Europe, Asia, Middle East and Africa. It is headquartered in Quebec, Canada and employs around 7,000 people. The company recorded revenues of $3,546.6 million in the fiscal year ended December 2012, an increase of 44% over 2011. The company's operating profit was $79.7 million in fiscal 2012, a decrease of 73.4% compared to 2011. Its net loss was $116 million in fiscal 2012, as compared to the net profit of $159.6 million in 2011. Reasons to Purchase: - Gain understanding of Valeant Pharmaceuticals International, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Valeant Pharmaceuticals International, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Valeant Pharmaceuticals International, Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.